New shot aims to silence hepatitis b virus in patients on long-term pills
NCT ID NCT06425341
First seen Nov 17, 2025 · Last updated May 15, 2026 · Updated 13 times
Summary
This study tests an experimental injection called HRS-5635, given alone or with other drugs, in 369 adults with chronic hepatitis B. Participants must already be on standard antiviral pills with undetectable virus levels. The main goal is to see if the treatment can lower or clear hepatitis B surface antigen from the blood, which would mean better disease control. This is a Phase 2 trial, so it is still early and focuses on safety and how well the drug works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nanfang Hospital
RECRUITINGGuangzhou, Guangdong, 510515, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.